AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06406257 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3M™ Bair Hugger™ Warming Unit
Description: Utilizing the 3M Temperature Management Unit to ensure intraoperative body temperature of elderly hip surgery patients remains consistent with their preoperative baseline, while patients in Group C receive no intervention.
Study NCT06694259 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pneumatic retinopexy with transscleral cryopexy
Description: Pneumatic retinopexy with transscleral cryopexy is a procedure used to treat certain types of rhegmatogenous retinal detachments.~Procedure steps:~Transscleral cryopexy: in this first step, the surgeon uses a cryoprobe applied to the sclera directly over the retinal tear. The cryoprobe emits extreme cold, creating a small, localized freeze that reaches the retina and seals the tear by causing a controlled scar to form. This scar tissue holds the retina in place and prevents further fluid from passing through the tear.~Gas bubble injection: after the cryopexy, a small gas bubble (usually sulfur hexafluoride (SF6) or perfluoropropane (C3F8)) is injected into the vitreous cavity. This bubble applies upward pressure on the retina, gently pressing it against the back wall of the eye, which aids in reattaching the retina.~Head positioning: for several days following the procedure, the patient must keep their head in a specific position so the gas bubble remains aligned with the retinal tear.
Study NCT06694259 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pneumatic retinopexy with laser photocoagulation
Description: Pneumatic retinopexy with laser photocoagulation is a minimally invasive procedure used to repair certain types of rhegmatogenous retinal detachments.~Procedure steps:~Gas bubble injection: a small gas bubble, usually sulfur hexafluoride (SF6) or perfluoropropane (C3F8), is injected into the vitreous cavity which rises and applies pressure to the detached retina, pressing it back against the eye wall and helping to reapproximate the retinal layers.~Laser photocoagulation: once the retina is positioned correctly, laser is used to create small burns around the retinal tear. This laser application causes a mild inflammatory response, creating a scar around the tear and effectively welding the retina to the underlying tissue. This seal prevents fluid from reaccumulating beneath the retina.~Head positioning: following the procedure, the patient must keep their head in a specific position for several days. This positioning ensures that the gas bubble stays aligned with the retinal tear.
Study NCT06441058 — intervention group
Intervention type: OTHER
Intervention: No patient treatment is associated with the study
Description: No patient treatment is associated with the study.
Study NCT04181281 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Contrast enhanced ultrasound
Description: This is a regular ultrasound scanner used with an ultrasound contrast agent injected through veins to allow for kidney perfusion acquisition.
Study NCT04181281 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Arterial Spin Labelling -Magnetic Resonance Imaging
Description: Arterial spin labelling is an MRI technique allow for measuring tissue perfusion. It uses magnetically labelled arterial blood water protons as a tracer.
Study NCT05394077 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Active Release Technique
Description: Using Active Release Technique
Study NCT05394077 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Abdominal Drawing-Maneuver
Description: Using Abdominal Drawing-Maneuver Technique
Study NCT05822869 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: EIT-guided mechanical ventilation strategy
Description: During prone ventilation, the PEEP level is adjusted based on EIT monitoring. The optimal PEEP is the lowest sum of collapse and overdistension percentages
Study NCT05822869 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Lung protective ventilation group
Description: Lung-protective ventilation strategy during prone positioning that continues the supine position.
Study NCT05089227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: treatment intervention
Description: for a total of 12 weeks, prophylactic heparin therapy during hospitalization followed by prophylactic oral anticoagulation with apixaban
Study NCT05089227 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: treatment standard
Description: during hospitalization prophylactic heparin therapy followed by management without prophylactic anticoagulation.
Study NCT05089565 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation
Description: Measurement of humeral and cell-mediated immune responses to SARS-CoV-2 vaccination
Study NCT05926206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Devimistat
Description: Escalation: Assigned dose level (mg/m2), IV over 120 minutes, Days 1 and 3 Cohort A: 500 mg/m2, IV over 120 minutes, Days 1 and 3 Cohort B: MTD mg/m2, IV over 240 minutes, Days 1 and 3
Study NCT05926206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Modified FOLFIRINOX
Description: Oxaliplatin- 85 mg/m2, IV over 120 minutes, day 1 Leucovorin/folinic acid- 400 mg/m2, IV over 90 minutes, day 1 Irinotecan- 150 mg/m2, IV over 90 minutes, day 1 5FU- 2400 mg/m2, IV over 42-48 hours after irinotecan, day 1
Study NCT05136391 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XTR003
Description: Single dose of 8.0-10 mCi of XTR003 will be injected on the first day of the study (Day 1). Serial whole-body PET imaging will be acquired after dose injection.
Study NCT04676243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quizartinib
Description: 20 mg coated tablets, orally administered
Study NCT04676243 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Treatment according to Physician's Choice
Description: Usually daunorubicin/ cytarabine or idarubicin/Cytarabine plus FLT3 inhibitor (usually midostaurin)
Study NCT04676243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard of Care Chemotherapy
Description: Daunorubicin/ Cytarabine or Idarubicin/Cytarabine
Study NCT03528681 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Zirconium Cyclosilicate 5g
Description: Suspension administered Sodium Zirconium Cyclosilicate 5g orally once daily for 28 days after the open label initial phase with suspension administered Sodium Zirconium Cyclosilicate 10g orally three times per day for at most 2 days.
Study NCT03528681 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Zirconium Cyclosilicate 10g
Description: Suspension administered Sodium Zirconium Cyclosilicate 10g orally once daily for 28 days after the open label initial phase with suspension administered Sodium Zirconium Cyclosilicate 10g orally three times per day for at most 2 days.
Study NCT03528681 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Suspension administered orally placebo once daily for 28 days after the open label initial phase with suspension administered Sodium Zirconium Cyclosilicate 10g orally three times per day for at most 2 days.
Study NCT05290467 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online antenatal care
Description: ANC will be provided by obstetricians, and health education will be provided online by midwives. Obstetricians will schedule appointments for the succeeding contacts/visits of the participants. CSOG-recommended prenatal care services will be provided to both the experimental and control groups, using different delivery strategies. Participants in the control group will be scheduled for 12 routine ANC visits, and those in the experimental group will be scheduled for 9 outpatient visits and additional 3 times of services through an online medical service platform. The obstetricians/midwives will train pregnant women how to monitor and record their weight, heart rate, blood pressure, urinary protein, blood glucose, and fetal movement at home. Messages, audio and video chats will be used at online ANC contacts to ensure service quality and accuracy of monitoring the results.
Study NCT06394622 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide + Fludarabine + Infusion of CAR-NKT Cells
Description: Biological: CD70 CAR-NKT cells. Drug: Cyclophosphamide. Drug: Fludarabine.
Study NCT04837404 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Ultrasound guided femoral access for complex PCI
Description: Ultrasound guided femoral access for complex PCI
Study NCT04837404 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Fluoroscopy guided femoral access for complex PCI
Description: Fluoroscopy guided femoral access for complex PCI
Study NCT05089227 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: biological assessment
Description: CBC, reticulocytes, haptoglobin, LDH, bilirubin
Study NCT05089227 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: biological assessment
Description: CBC, reticulocytes, haptoglobin, LDH, bilirubin
Study NCT04895436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Oral tablet
Study NCT04895436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: Intravenous (IV) infusion
Study NCT06008379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 7MW3711 for injection
Description: IV administration of 7MW3711, Q3W, 3 weeks a cycle
Study NCT06008379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 7MW3711 for injection
Description: IV administration of 7MW3711, the dosage regimen including dosage and dosing frequency for cohort expansion is conformed on basis of the data in part 1
Study NCT06152354 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rotary system
Description: crown down technique using Kedo-SG file rotary system using endodontic motor
Study NCT06152354 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Manual files
Description: instrumentation were done by step back technique using K- file (Mani ) from size 15 to size 35 in quarter pull turn motion apically
Study NCT06464406 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality condition
Description: Participants will watch a video on a virtual reality headset during the completion of the maximal cardiorespiratory exercise test.
Study NCT06210295 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: Laboratory investigtions
Description: To study causes of anemia in SLE in our environment and causes of refractory type and its relation to bone marrow affection and different drugs used in SLE
Study NCT05313464 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: parent-pushed enteral feeding
Description: skin-to-skin enteral nutrition pushed by the parent
Study NCT05313464 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: syringe-push enteral feeding
Description: skin to skin nutrition with syringe pump
Study NCT06464406 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control condition
Description: Participants will complete the maximal cardiorespiratory exercise test under control conditions without video, music, or other distractions.
Study NCT03835338 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary Vein Isolation
Description: Pulmonary Vein Isolation by RF Ablation
Study NCT03835338 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulmonary Vein Isolation
Description: Pulmonary Vein Isolation by RF Ablation
Study NCT03835338 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LAA Isolation
Description: LAA Isolation by RF Ablation
Study NCT03835338 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LAA Occlusion
Description: LAA Occlusion by implantation of the WATCHMAN LAAC Device
Study NCT04886765 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALMB-0168
Description: ALMB-0168 will be administered intravenously until either the disease progresses or intolerable toxicity occurs.
Study NCT04723069 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Control Group
Description: metronidazole tablets + doxycycline hyclate tablets, are consecutively taken for 14 days, while Fuke Qianjin capsule simulation is consecutively taken for 28 days.
Study NCT04723069 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Test Group
Description: metronidazole tablets + doxycycline hyclate tablets simulant are consecutively taken for 14 days, while Fuke Qianjin capsule is consecutively taken for 28 days.
Study NCT06122493 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tirelizumab
Description: immunotherapy, 200 mg on day 1 per 3 weeks
Study NCT06122493 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Nab paclitaxel
Description: chemotherapy, 175 mg/m² on day 1 per 3 weeks
Study NCT06122493 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Carboplatin
Description: chemotherapy, AUC=5 on day 1 per 3 weeks
Study NCT06122493 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Radiotherapy
Description: Patients without disease progression after four cycles of chemoimmunotherapy receive radiotherapy targeting esophageal lesions and positive lymph nodes, with a total dose of 50.4 Gy delivered over 28 fractions.
Study NCT05277259 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Extracorporeal Shock Wave Therapy
Description: Device named 'Elettronica Pagani,Italy' and will be used with radial probe.
Study NCT04934202 — intervention group
Intervention type: OTHER
Intervention: Teleconsultation
Description: Teleconsulting physicians will subject patients to a standardized questionnaire that will look for the following symptoms:~* General signs: Anorexia, fatigue, new hospitalization, weight loss,~* Respiratory signs: recent dyspnoea, chest discomfort, chest pain, new cough, abnormal lung CT scan since discharge~* Neurological signs: headache, paraesthesia, anosmia, limb paralysis~* Digestive signs: abdominal pain, diarrhoea, constipation, nausea, vomiting~Edition 2021~◌ Cognitive signs using the Q3PC questionnaire (10): memory loss, slowness in reasoning, activity planning or problem solving, concentration, attention difficulties
Study NCT05277259 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesiotaping
Description: Elastic band to be used to stretch the upper trapezius muscle in the desired direction.
Study NCT05277259 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physical Therapy
Description: Conventional physical therapy will be consisted of hotpack, therapeutic ultrasound and tens applications.
Study NCT04934202 — intervention group
Intervention type: OTHER
Intervention: Outpatient clinic
Description: During a day hospitalization planned during the teleconsultation, patients will benefit from the following multidisciplinary assessment.~* General clinical examination~* Assessment of the state of health~* Respiratory assessment~* Pulmonary CT assessment~* Cognitive evaluation~* Cardiological evaluation~* Renal assessment~* Immunological evaluation
Study NCT04831450 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab-Rwlc
Description: 350 mg Cemiplimab administered via intravenous infusion over 30 minutes on Day 1 of a 21-day cycle.
Study NCT05509621 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Supine Position on Physiological Parameters in Mechanically Ventilated Preterm Newborns
Description: Preterm neonates who receive mechanical ventilation support and meet the study criteria will be provided with daily routine nursing care. Afterward, when it is time for positioning, the infant will be randomly placed in positions assigned according to the randomization. After positioning, data will not be collected for the first 30 minutes of each positioning in order to ensure the stability of the neonate. Starting from the 30th minute, the heart rate and oxygen saturation of the preterm neonate will be checked on the monitor at 15-minute intervals over the course of 90 minutes, and the respiratory rate will be counted and recorded for 1 minute by the researcher. For each position, the procedures will be repeated in the same way and the values will be recorded.
Study NCT05509621 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Prone Position on Physiological Parameters in Mechanically Ventilated Preterm Newborns
Description: Preterm neonates who receive mechanical ventilation support and meet the study criteria will be provided with daily routine nursing care. Afterward, when it is time for positioning, the infant will be randomly placed in positions assigned according to the randomization. After positioning, data will not be collected for the first 30 minutes of each positioning in order to ensure the stability of the neonate. Starting from the 30th minute, the heart rate and oxygen saturation of the preterm neonate will be checked on the monitor at 15-minute intervals over the course of 90 minutes, and the respiratory rate will be counted and recorded for 1 minute by the researcher. For each position, the procedures will be repeated in the same way and the values will be recorded.
Study NCT05011552 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Compassion, Health, and Empowerment (SHE)
Description: The SHE intervention includes 8 weekly sessions and 24-hour access to the intervener for any additional support needed. The first and last sessions will be delivered over the phone with the woman based on a brochure. The brochure describes the four major components: a) IPV information, b) Danger Assessment, c) Safety Planning, and d) Resources. It will be discussed with the woman in an interactive manner so that the woman is encouraged to describe her experiences and choose her options as they proceed. Session 2-7 focus on providing mental health self-care resources, which are deep breathing, progressive muscle relaxation, visualization, general introduction and overview of self-compassion, mindfulness, and loving-kindness.
Study NCT05011552 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: The Control Condition
Description: Women randomized to the control group will be provided with the same brochure and mental health care resources.
Study NCT05509621 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of left lateral Position on Physiological Parameters in Mechanically Ventilated Preterm Newborns
Description: Preterm neonates who receive mechanical ventilation support and meet the study criteria will be provided with daily routine nursing care. Afterward, when it is time for positioning, the infant will be randomly placed in positions assigned according to the randomization. After positioning, data will not be collected for the first 30 minutes of each positioning in order to ensure the stability of the neonate. Starting from the 30th minute, the heart rate and oxygen saturation of the preterm neonate will be checked on the monitor at 15-minute intervals over the course of 90 minutes, and the respiratory rate will be counted and recorded for 1 minute by the researcher. For each position, the procedures will be repeated in the same way and the values will be recorded.
Study NCT05509621 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of right lateral Position on Physiological Parameters in Mechanically Ventilated Preterm Newborns
Description: Preterm neonates who receive mechanical ventilation support and meet the study criteria will be provided with daily routine nursing care. Afterward, when it is time for positioning, the infant will be randomly placed in positions assigned according to the randomization. After positioning, data will not be collected for the first 30 minutes of each positioning in order to ensure the stability of the neonate. Starting from the 30th minute, the heart rate and oxygen saturation of the preterm neonate will be checked on the monitor at 15-minute intervals over the course of 90 minutes, and the respiratory rate will be counted and recorded for 1 minute by the researcher. For each position, the procedures will be repeated in the same way and the values will be recorded.
Study NCT05509621 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Quarter prone Position on Physiological Parameters in Mechanically Ventilated Preterm Newborns
Description: Preterm neonates who receive mechanical ventilation support and meet the study criteria will be provided with daily routine nursing care. Afterward, when it is time for positioning, the infant will be randomly placed in positions assigned according to the randomization. After positioning, data will not be collected for the first 30 minutes of each positioning in order to ensure the stability of the neonate. Starting from the 30th minute, the heart rate and oxygen saturation of the preterm neonate will be checked on the monitor at 15-minute intervals over the course of 90 minutes, and the respiratory rate will be counted and recorded for 1 minute by the researcher. For each position, the procedures will be repeated in the same way and the values will be recorded.
Study NCT06512233 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LMW Heparin 5000 U/ML-Aspirin 75 MG
Description: Arm 1
Study NCT06512233 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LMW Heparin 5000 U/ML
Description: Arm 2
Study NCT04775043 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: HFRDIS questionnaire completion
Description: HFRDIS Questionnaire (Hot Flash Related Daily Interference Scale) completion
Study NCT06302283 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: Survey (online or paper) on caregiving burden and bereavement